Jane S. Ricciuti, RPh, MS


May 04, 2005

In This Article


The US Food and Drug Administration (FDA) has approved Baraclude (entecavir) tablets and oral solution for use in the treatment of chronic hepatitis B virus (HBV) infection in adults. Entecavir is a guanosine nucleoside analogue with selective activity against HBV.

This month's column includes a summary of the following:

Ammonia Detoxicants

  • Ammonul (sodium phenylacetate and sodium benzoate) Injection

Anti-infective Agents

  • Baraclude (entecavir) Tablets and Oral Solution

Neurologic Agents

  • Namenda (memantine) Oral Solution

Ophthalmic Agents

  • Retisert (fluocinolone acetonide) Intravitreal Implant

Osteoporosis Agents

  • Fosamax Plus D (alendronate and vitamin D3) Tablets

Pulmonology Agents

  • Asmanex Twisthaler (mometasone furoate) Inhaler